News Website

First patient dosed in Gesynta Pharma's phase II trial in endometriosis - Biostock

First patient dosed in Gesynta Pharma's phase II trial in endometriosis Biostock

Published: March 18, 2026, 11:33 a.m.

Read Full Article

Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - ACCESS Newswire

Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis ACCESS Newswire

Published: March 18, 2026, 10:13 a.m.

Read Full Article

FinancialContent - Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - FinancialContent

FinancialContent - Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis FinancialContent

Published: March 18, 2026, 10 a.m.

Read Full Article

Limited evidence for medicinal cannabis in most mental health conditions - australianpharmacist.com.au

Limited evidence for medicinal cannabis in most mental health conditions australianpharmacist.com.au

Published: March 18, 2026, 4:12 a.m.

Read Full Article

Medicinal cannabis shows potential in reducing pelvic pain – Otago study - Pharmacy Today

Medicinal cannabis shows potential in reducing pelvic pain – Otago study Pharmacy Today

Published: March 18, 2026, 2:14 a.m.

Read Full Article

Esperance physio Kendall Carmody publishes long-awaited endometriosis research - WA Country Health Service

Esperance physio Kendall Carmody publishes long-awaited endometriosis research WA Country Health Service

Published: March 18, 2026, 12:49 a.m.

Read Full Article

Robotic interposition of the mesorectum during low anterior resection of the rectum for endometriosis using tissue perfusion assessment with indocyanine green.

Rectal endometriosis is a serious disease, and its surgical treatment belongs among demanding procedures, often requiring a multidisciplinary approach. It is associated with a significant risk of peri- and postoperative …

Published: March 18, 2026, midnight

Read Full Article

deep rectal endometriosis indocyanine green mesorectum rectovaginal fistula segmental resection tissue perfusion

1 in 10: Endometriosis Explained - newscentermaine.com

1 in 10: Endometriosis Explained newscentermaine.com

Published: March 17, 2026, 9:24 p.m.

Read Full Article

1 in 10: Endometriosis Explained | Now streaming on NEWS CENTER Maine + - newscentermaine.com

1 in 10: Endometriosis Explained | Now streaming on NEWS CENTER Maine + newscentermaine.com

Published: March 17, 2026, 8:31 p.m.

Read Full Article

Gesynta Pharma doses first patient in Phase II NOVA trial - MSN

Gesynta Pharma doses first patient in Phase II NOVA trial MSN

Published: March 17, 2026, 6:25 p.m.

Read Full Article

Latest Articles

First patient dosed in Gesynta Pharma's phase II trial in endometriosis - Biostock

Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - ACCESS Newswire

FinancialContent - Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - FinancialContent

Limited evidence for medicinal cannabis in most mental health conditions - australianpharmacist.com.au

Medicinal cannabis shows potential in reducing pelvic pain – Otago study - Pharmacy Today

Esperance physio Kendall Carmody publishes long-awaited endometriosis research - WA Country Health Service

Robotic interposition of the mesorectum during low anterior resection of the rectum for endometriosis using tissue perfusion assessment with indocyanine green.

1 in 10: Endometriosis Explained - newscentermaine.com

1 in 10: Endometriosis Explained | Now streaming on NEWS CENTER Maine + - newscentermaine.com

Gesynta Pharma doses first patient in Phase II NOVA trial - MSN

Subscribe to Our Newsletter